February 10th-11th，Deputy Secretary of the Party Committee of Shaanxi Pharmaceutical Group、Li Yuan, general manager and chairman stake betting appstake betting appof Eurasia International Health Industry Group, led a team to inspect Shanghai Institute of Biology and WuXi Biologics。Xu Danxia, Director of Eurasia International Health Industry Group，Supervisor Zhu Yifei、Li Ji and others attended together。
February 10，Li Yuan and his party went to Shanghai Institute of Biology，With the Secretary of the Party Committee of Shanghai Institute of Biology、General Manager Li Xiuling，Dong Jun, head of the International Trade Department of Sinopharm China Biotechnology Company, held a discussion and exchange，And visited the vaccine production workshop。
Symposium
Li Xiuling warmly welcomes the visit of Shaanxi Pharmaceutical Group and Eurasia International Health Industry Group，Detailed introduction to the development history of Shanghai Institute of Biology、R&D and production base layout、R&D pipeline and key products, etc.。Dong Jun introduced China Biotech’s vaccine export situation and typical cases，Hope to unite Shaanxi Pharmaceutical Group and Eurasia International Health Industry Group，Accelerate the pace of export of vaccine products。
Visit
Li Yuan spoke highly of the innovative development of China National Biological Corporation and Shanghai Institute of Biology，Confidence in joint vaccine export cooperation。He said，The next step will be to speed up the connection with international resources，Clear the specific matters of project cooperation，stake sports betting appstake online sports bettingAnd take this as an opportunity，Deepen the supply chain strategic cooperation between the two parties。
February 11，The delegation came to WuXi Biologics，Visited the laboratory and production workshop。Chief Technology Officer of WuXi Biologics、Vice President Zhou Weichang focused on the global planning and layout of WuXi Biologics、Biotechnology Platform、Service outsourcing capabilities, etc.，Expressed the hope that both parties will strengthen cooperation，Utilize WuXi Biologics’ world-leading biopharmaceutical R&D platform and resources，To empower and increase efficiency for the high-quality development of Shaanxi Pharmaceutical Group and Eurasia International Health Industry Group。
Symposium
Li Yuan introduced the basic situation of Shaanxi Pharmaceutical Group and Eurasia International Health Industry Group，around“14th Five-Year Plan” development goals and key projects，Proposed the research and development of biomedicine between the two parties、Service outsourcing business、Conception of cooperation in product pipeline and other aspects，And arranged follow-up docking matters。Zhou Weichang gave a positive response，People from both sides fully exchanged views on cooperation models and other matters。
Photograph
This My stake betting appMy stake betting appinspection is an in-depth study of vaccine and biomedical service outsourcing，Strengthened cooperative relations with all parties，To implement the groupKey projects of the “14th Five-Year Plan”、Promoting the high-quality development stake betting appstake betting appof Eurasia International Health Industry Group has a positive role in promoting。
ParticipateInspectionAlso the group chief accountant Lei Yongquan、General Manager Assistant Tong Zhuobin、Liu Yanlin, Secretary of the Party Committee of Xi'an Zhengda Pharmaceutical、Cheng Xuzhao, deputy general manager of the industrial company、Su Bo, Deputy General Manager of Traditional Chinese Medicine Investment Company、Vice President of the Institute of Medical Research Fan Bo，andGroupRelevant department heads.
